Katherine Laessig

Dr. Laessig has over 16 years of regulatory experience at the US Food and Drug Administration (FDA) from 1999 through 2015. Most recently, she served as the Deputy Director of the Division of Anti-Infective Products (DAIP) for eight years and was responsible for the review of antimicrobial drug and biologic products for the treatment as well as prevention of infectious diseases. Prior to joining DAIP, she held several positions of increasing responsibility in the Division of Antiviral Products. Her major area of expertise is antimicrobial product development. She remained active in clinical practice with a weekly HIV/AIDS clinic at the Whitman Walker Clinic in Washington, DC from 20002016. Dr. Laessig began her career as an infectious disease specialist with Kaiser Permanente in the Washington, DC metropolitan area. She received her medical degree from the University of Maryland in Baltimore in 1992 and completed an internal medicine residency and infectious diseases fellowship, both at The George Washington University Medical Center in Washington, DC. She graduated from Cornell University in 1988 with a Bachelor of Arts in biology and a concentration in microbiology. She is board certified in infectious diseases and is a member of the Infectious Diseases Society of America.